Hiromitsu Jinno

1.2k total citations
71 papers, 863 citations indexed

About

Hiromitsu Jinno is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hiromitsu Jinno has authored 71 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 24 papers in Cancer Research and 19 papers in Molecular Biology. Recurrent topics in Hiromitsu Jinno's work include Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (18 papers) and Cancer Treatment and Pharmacology (16 papers). Hiromitsu Jinno is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (18 papers) and Cancer Treatment and Pharmacology (16 papers). Hiromitsu Jinno collaborates with scholars based in Japan, United States and United Kingdom. Hiromitsu Jinno's co-authors include Tetsu Hayashida, Yuko Kitagawa, Akiko Matsumoto, Masaki Kitajima, Yuko Kitagawa, Masakazu Ueda, Tadashi Ikeda, Kazuhíko Ishihara, Hisae Iinuma and Maiko Takahashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiromitsu Jinno

68 papers receiving 839 citations

Peers

Countries citing papers authored by Hiromitsu Jinno

Since Specialization

Citations

This map shows the geographic impact of Hiromitsu Jinno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Jinno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Jinno more than expected).

Fields of papers citing papers by Hiromitsu Jinno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Jinno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Jinno. The network helps show where Hiromitsu Jinno may publish in the future.

Co-authorship network of co-authors of Hiromitsu Jinno

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromitsu Jinno. A scholar is included among the top collaborators of Hiromitsu Jinno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromitsu Jinno. Hiromitsu Jinno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinicopathological features and prognosis of breast cancer with low HER2 status evaluated by fluorescence in situ hybridization 2024 ·Oncology Letters ·(unknown), (unknown), Akiko Matsumoto, (unknown), Hiromitsu Jinno	0
2	Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry 2024 ·Breast Cancer ·Shinsuke Sasada, Hiraku Kumamaru, Naoki Hayashi, Naoko Kinukawa, Masakazu Toi, Hiromitsu Jinno, Shigehira Saji	4
3	Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer 2023 ·Japanese Journal of Clinical Oncology ·Akiko Matsumoto, Hiromitsu Jinno, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuko Sasajima	1
4	Acute arterial occlusive disease due to tumor thrombus from lung metastasis of breast cancer with cartilaginous and osseous metaplasia: a case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Akiko Matsumoto, (unknown), (unknown), (unknown), (unknown), (unknown), Yuko Sasajima, Hiromitsu Jinno	0
5	Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system 2022 ·Cancer Science ·Tetsu Hayashida, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Akiko Matsumoto, (unknown), Hiromitsu Jinno, Hiroaki Miyata, Yuko Kitagawa	8
6	Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry 2022 ·Breast Cancer ·Mitsuo Terada, Minoru Miyashita, Hiraku Kumamaru, Hiroaki Miyata, Kenji Tamura, (unknown), Etsuyo Ogo, Masayuki Nagahashi, Sota Asaga, Yasuyuki Kojima, Takayuki Kadoya, Kenjiro Aogi, Naoki Niikura, Kotaro Iijima, Naoki Hayashi, Makoto Kubo, Yutaka Yamamoto, Hiromitsu Jinno	11
7	Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan 2022 ·Breast Cancer ·Akihiko Shimomura, Masayuki Nagahashi, Hiraku Kumamaru, (unknown), Sota Asaga, Naoki Hayashi, Kotaro Iijima, Takayuki Kadoya, (unknown), Makoto Kubo, Minoru Miyashita, Hiroaki Miyata, Naoki Niikura, Etsuyo Ogo, Kenji Tamura, (unknown), Masayuki Yoshida, Yutaka Yamamoto, Shigeru Imoto, Hiromitsu Jinno	8
8	Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial 2018 ·BMC Cancer ·Tetsu Hayashida, Hiromitsu Jinno, (unknown), Hiroki Sato, Akira Matsui, Toshihiro Sakurai, Hiroaki Hattori, Shin Takayama, Masahiro Wada, Maiko Takahashi, (unknown), Tomoko Seki, Aiko Nagayama, Akiko Matsumoto, Yuko Kitagawa	13
9	Expression of potential biomarkers associated with homologous recombination repair in patients with ovarian or triple-negative breast cancer 2016 ·Cancer Biomarkers ·Hiroyuki Nomura, Fumio Kataoka, Daisuke Aoki, Hiromitsu Jinno, Yuko Kitagawa, Yuji Sato, Chris Womack, (unknown), Darren Hodgson, Mark J. O’Connor, Chris Harbron, Xiaolu Yin	9
10	[A Case of Advanced Breast Cancer in Which Marked Improvement of Joint Pain Was Obtained with Stepwise Dose Reduction of Trastuzumab Emtansine (T-DM1)]. 2015 ·PubMed ·(unknown), (unknown), Yoko Harada, (unknown), (unknown), (unknown), Takahisa Yoshikawa, (unknown), (unknown), Hiromitsu Jinno, Yuko Kitagawa	0
11	Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis 2014 ·JNCI Journal of the National Cancer Institute ·Aiko Nagayama, Tetsu Hayashida, Hiromitsu Jinno, Maiko Takahashi, Tomoko Seki, Akiko Matsumoto, Takeshi Murata, Hutan Ashrafian, Thanos Athanasiou, Koji Okabayashi, Yuko Kitagawa	57
12	[Synchronous male bladder cancer and breast cancer - a case report]. 2014 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Takahisa Yoshikawa, (unknown), (unknown), Akihiko Nakamura, (unknown), Yasumasa Miyazaki, (unknown), Hiromitsu Jinno, Yuko Kitagawa	1
13	An E2F1-HOXB9 Transcriptional Circuit Is Associated with Breast Cancer Progression 2014 ·PLoS ONE ·(unknown), Tetsu Hayashida, Maiko Takahashi, (unknown), Hiroshi Okazaki, Hiromitsu Jinno, Yuko Kitagawa	17
14	HOXB9 Expression Promoting Tumor Cell Proliferation and Angiogenesis Is Associated with Clinical Outcomes in Breast Cancer Patients 2012 ·Annals of Surgical Oncology ·(unknown), Tetsu Hayashida, Hiromitsu Jinno, Shigemichi Hirose, (unknown), Maiko Takahashi, Shyamala Maheswaran, Makio Mukai, Yuko Kitagawa	44
15	Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine‐based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel 2008 ·International Journal of Cancer ·Ryohei Miyata, Masakazu Ueda, Hiromitsu Jinno, Tomohiro Konno, Kazuhíko Ishihara, Nobutoshi Ando, Yuko Kitagawa	25
16	Development of Gene Vectors for Pinpoint Targeting to Human Hepatocytes by Cationically Modified Polymer Complexes 2007 ·European Surgical Research ·Naokazu Chiba, Masakazu Ueda, (unknown), Hiromitsu Jinno, Junji Watanabe, Kazuhíko Ishihara, Masaki Kitajima	16
17	Evaluation of the in vivo efficacy, toxicity and lymphatic drainage of loco-regional administered polymer-lipid hybrid nanoparticles (PLN) loaded with doxorubicin in a murine solid tumor model 2006 ·Cancer Research ·(unknown), Masakazu Ueda, Hiromitsu Jinno, (unknown), Tadashi Ikeda, Junji Watanabe, (unknown), Masaki Kitajima	5
18	Anti‐tumor effect in an in vivo model by human‐derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties 2006 ·Cancer Science ·Hiroshi Yagi, Masakazu Ueda, Hiromitsu Jinno, Koichi Aiura, Shuji Mikami, Hiroko Tada, Masaharu Seno, Hidenori Yamada, Masaki Kitajima	3
19	Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells 2002 ·International Journal of Oncology ·Hiromitsu Jinno, Mitchell S. Steiner, Kathryn Nason-Burchenal, Michael P. Osborne, Nitin Telang	10
20	Negative Growth Regulation of Oncogene‐transformed Human Breast Epithelial Cells by Phytochemicals: Role of Apoptosis 1999 ·Annals of the New York Academy of Sciences ·Meena Katdare, Hiromitsu Jinno, Michael P. Osborne, Nitin Telang	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact